EE03071B1 - Karbasolooni derivaadid ja nende saamise protsess - Google Patents

Karbasolooni derivaadid ja nende saamise protsess

Info

Publication number
EE03071B1
EE03071B1 EE9400092A EE9400092A EE03071B1 EE 03071 B1 EE03071 B1 EE 03071B1 EE 9400092 A EE9400092 A EE 9400092A EE 9400092 A EE9400092 A EE 9400092A EE 03071 B1 EE03071 B1 EE 03071B1
Authority
EE
Estonia
Prior art keywords
formula
methyl
group
chem
production process
Prior art date
Application number
EE9400092A
Other languages
English (en)
Estonian (et)
Inventor
Bod P�ter
Hars�nyi K�lm�n
Trischler Ferenc
Fekecs Va
Csehi Attila
Heged�s B�la
Mersich n�e Don�t �va
Szab� n�e Koml�si Gy�rgyi
Horv�th n�e Sziki Erika
Original Assignee
Richter Gedeon Vegy�Szeti Gy�R Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26318102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE03071(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from HU9203222A external-priority patent/HU212934B/hu
Priority claimed from HU9203223A external-priority patent/HU212785B/hu
Application filed by Richter Gedeon Vegy�Szeti Gy�R Rt. filed Critical Richter Gedeon Vegy�Szeti Gy�R Rt.
Publication of EE03071B1 publication Critical patent/EE03071B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
EE9400092A 1992-10-14 1994-07-19 Karbasolooni derivaadid ja nende saamise protsess EE03071B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9203222A HU212934B (en) 1992-10-14 1992-10-14 Process for producing novel alkoxalylated carbazolone derivatives
HU9203223A HU212785B (en) 1992-10-14 1992-10-14 Process for producing of a carbazolone derivative

Publications (1)

Publication Number Publication Date
EE03071B1 true EE03071B1 (et) 1998-02-16

Family

ID=26318102

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400092A EE03071B1 (et) 1992-10-14 1994-07-19 Karbasolooni derivaadid ja nende saamise protsess

Country Status (20)

Country Link
US (2) US5416221A (cs)
EP (1) EP0595111B2 (cs)
JP (1) JP3378315B2 (cs)
KR (1) KR100289912B1 (cs)
CN (2) CN1052979C (cs)
AT (1) ATE157973T1 (cs)
CA (1) CA2106642C (cs)
CZ (1) CZ284223B6 (cs)
DE (1) DE69313771T3 (cs)
DK (1) DK0595111T4 (cs)
EE (1) EE03071B1 (cs)
ES (1) ES2106936T5 (cs)
GR (1) GR3025599T3 (cs)
HR (1) HRP931292B1 (cs)
PL (2) PL174526B1 (cs)
RO (1) RO115799B1 (cs)
RU (1) RU2119914C1 (cs)
SI (1) SI9300537B (cs)
SK (1) SK281243B6 (cs)
UA (2) UA26893C2 (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226135B1 (en) * 2000-03-28 2008-05-28 Richter Gedeon Nyrt Intermediate of ondansetron and process for its production
KR100368895B1 (ko) * 2000-03-30 2003-01-24 하나제약 주식회사 1,2,3,9-테트라하이드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카바졸-4-온의 제조방법
AU2002230935A1 (en) * 2000-10-30 2002-05-15 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
RU2207340C2 (ru) * 2001-08-10 2003-06-27 Ципла Лтд. Способ получения 1,2,3,9-тетрагидро-9-метил-3-[(2-метил-1н-имидазол-1-ил)метил]-4н-карбазол -4-она или его фармацевтически приемлемых солей
EP1499623B1 (en) * 2002-04-29 2007-06-13 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-¬(2-methyl-1h-imidazol-1-yl)methyl|-4h-carbazol-4-one
KR20040104677A (ko) * 2002-04-30 2004-12-10 비오갈 기오기스제르갸르 알티. 신규의 온단세트론 결정 형태, 그 제조 방법, 그 신규의결정 형태를 함유하는 약학 조성물 및 이들을 이용한구역질 치료 방법
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
JP2007501284A (ja) * 2003-06-10 2007-01-25 スミスクライン ビーチャム コーポレーション テトラヒドロカルバゾール誘導体およびそれらの薬学的使用
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
GEP20094682B (en) * 2004-07-12 2009-05-10 Cadila Healthcare Ltd Tricyclic pyrazole derivatives as cannabinoid receptor modulators
US7696356B2 (en) * 2004-08-17 2010-04-13 Taro Pharmaceutical Industries Limited Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom
WO2006046253A1 (en) * 2004-10-26 2006-05-04 Ipca Laboratories Limited A one-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1h-imidazole-1-yl)methyl]-4h-carbazol-4-o
CN101084190B (zh) * 2004-12-27 2011-01-26 埃科特莱茵药品有限公司 作为crth2受体拮抗剂的2,3,4,9-四氢-1h-咔唑衍生物
CN115677561B (zh) * 2022-11-01 2024-04-05 常州兰陵制药有限公司 一种1,2,3,4-四氢-9-甲基-4h-咔唑酮及其合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3579534A (en) * 1969-05-09 1971-05-18 American Cyanamid Co Tetrahydrocarbazolecarboxylates
PH22672A (en) * 1984-01-25 1988-11-14 Glaxo Group Ltd Imidazolylmethyltetrahydrocarbazolone derivatives, composition and method of use thereof
CN1011237B (zh) * 1984-01-25 1991-01-16 格拉克索公司 1，2，3，9-四氢-3-[(2-甲基-1h-咪唑-1-基)甲基]-4h-咔唑-4-酮类和其盐以及溶剂化物的制备
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8617994D0 (en) * 1986-07-23 1986-08-28 Glaxo Group Ltd Heterocyclic compounds
GB8628473D0 (en) * 1986-11-28 1987-01-07 Glaxo Group Ltd Chemical compounds
JPH01258673A (ja) * 1987-10-22 1989-10-16 Glaxo Group Ltd ケトン誘導体

Also Published As

Publication number Publication date
DK0595111T3 (da) 1998-04-14
PL174173B1 (pl) 1998-06-30
SK111093A3 (en) 1994-11-09
CA2106642C (en) 2005-08-16
EP0595111B1 (en) 1997-09-10
PL300685A1 (en) 1994-04-18
RO115799B1 (ro) 2000-06-30
KR100289912B1 (ko) 2001-09-17
CA2106642A1 (en) 1994-04-15
PL174526B1 (pl) 1998-08-31
UA26893C2 (uk) 1999-12-29
JP3378315B2 (ja) 2003-02-17
CN1052979C (zh) 2000-05-31
CN1089941A (zh) 1994-07-27
ES2106936T3 (es) 1997-11-16
HRP931292A2 (en) 1994-12-31
EP0595111B2 (en) 2001-08-16
US5478949A (en) 1995-12-26
SI9300537A (en) 1994-06-30
CN1083430C (zh) 2002-04-24
US5416221A (en) 1995-05-16
JPH06293734A (ja) 1994-10-21
SK281243B6 (sk) 2001-01-18
ATE157973T1 (de) 1997-09-15
DE69313771T2 (de) 1998-02-12
ES2106936T5 (es) 2001-12-16
DK0595111T4 (da) 2001-10-22
CZ284223B6 (cs) 1998-09-16
CZ215693A3 (en) 1994-05-18
SI9300537B (sl) 2003-02-28
DE69313771D1 (de) 1997-10-16
HRP931292B1 (en) 1999-08-31
KR940009152A (ko) 1994-05-20
DE69313771T3 (de) 2002-04-18
UA27022C2 (uk) 2000-02-28
CN1235967A (zh) 1999-11-24
RU2119914C1 (ru) 1998-10-10
EP0595111A1 (en) 1994-05-04
GR3025599T3 (en) 1998-03-31

Similar Documents

Publication Publication Date Title
EE03071B1 (et) Karbasolooni derivaadid ja nende saamise protsess
HUT57722A (en) Process for producing azaspiran derivatives and pharmaceutical compositions comprising such compounds
HUT47550A (en) Process for producing tetrazole derivatives
HUT68057A (en) 2-[1-(1,3-thiazolin-2-yl)-azetidin-3-yl]-thio-carbapeneme derivatives, pharmaceutical compositions containing them and process for their production
DK0625147T3 (da) Fremgangsmåde til fremstilling af taxanderivater
AU1120095A (en) Novel imidazole derivative and process for producing the same
DE69226815D1 (de) 1-Methyl-carbapenemderivate, deren Herstellung und Verwendung als Antibiotika
HUT59378A (en) Process for producing urea derivatives and pharmaceutical compositions comprising such compounds
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
AU628521B2 (en) Improvements in or relating to organic compounds
DK0597423T3 (da) Azetidinonforbindelse og fremgangsmåde til fremstilling deraf
HU9200172D0 (en) Substituted 1,2,3,4-tetrahydro-cyclopenta/b/indole-and 1,2,3,3a,4,8a-hexahydro-cyclopenta/b/indole derivatives, their intermediate products, process for their production and medical preparations containing them
MY105538A (en) Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them.
DK0717042T3 (da) Fremgangsmåde til fremstilling af 1-(4,5-dihydro-2-thiazolyl)-3-azetidin-thiol-derivater
DE3781879D1 (de) Anthracyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE171942T1 (de) 1-piperazinyl-2-butene und 2-butyne, zwischenverbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE168371T1 (de) 5-amino-5,6,7,8-tetrahydrochinoline und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE247641T1 (de) Pyridin-zwischenprodukte, verwendbar zur herstellung von beta-adrenergischen rezeptor- agonisten
DE69204480D1 (de) Anilinderivate und Verfahren zu ihrer Herstellung.
ATE151422T1 (de) 8-azabicyclo(3.2.1>octylalkylthiazolidinone, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
NZ332245A (en) Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them
ATE52510T1 (de) Benzo(c>-1,5-naphthyridine, ein verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.
ES2074770T3 (es) Procedimiento de preparacion de derivados de 1,3-dioxano-4,6-diona.
DE68909143D1 (de) Prostaglandin-Vorläufer und ihre Herstellung.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

MM4A Lapsed by not paying the annual fees

Effective date: 20090719